These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 32361312

  • 1. Generation of human iPS cell line IBCHi002-A from spinocerebellar ataxia type 3/Machado-Joseph disease patient's fibroblasts.
    Ciolak A, Krzyzosiak WJ, Kozlowska E, Fiszer A.
    Stem Cell Res; 2020 May; 45():101796. PubMed ID: 32361312
    [Abstract] [Full Text] [Related]

  • 2. Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A.
    Hayer SN, Schelling Y, Huebener-Schmid J, Weber JJ, Hauser S, Schöls L.
    Stem Cell Res; 2018 Jul; 30():171-174. PubMed ID: 29936336
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.
    Ouyang S, Xie Y, Xiong Z, Yang Y, Xian Y, Ou Z, Song B, Chen Y, Xie Y, Li H, Sun X.
    Stem Cells Dev; 2018 Jun 01; 27(11):756-770. PubMed ID: 29661116
    [Abstract] [Full Text] [Related]

  • 6. Generation of induced pluripotent stem cell line (ZZUi0026-A) from a patient with spinocerebellar ataxia type 3.
    Fang J, Wang Y, Wang Z, Sun H, Zhang Q, Yang J, Liu Y, Liu H, Shi C, Xu Y, Zhang X, Kan Q.
    Stem Cell Res; 2021 May 01; 53():102205. PubMed ID: 34087977
    [Abstract] [Full Text] [Related]

  • 7. Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells.
    Ou Z, Luo M, Niu X, Chen Y, Xie Y, He W, Song B, Xian Y, Fan D, OuYang S, Sun X.
    Biomed Res Int; 2016 May 01; 2016():6701793. PubMed ID: 27847820
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preimplantation Genetic Testing of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease-Robust Tools for Direct and Indirect Detection of the ATXN3 (CAG)n Repeat Expansion.
    Lian M, Tan VJ, Taguchi R, Zhao M, Phang GP, Tan AS, Liu S, Lee CG, Chong SS.
    Int J Mol Sci; 2024 Jul 24; 25(15):. PubMed ID: 39125643
    [Abstract] [Full Text] [Related]

  • 10. CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells.
    He L, Wang S, Peng L, Zhao H, Li S, Han X, Habimana JD, Chen Z, Wang C, Peng Y, Peng H, Xie Y, Lei L, Deng Q, Wan L, Wan N, Yuan H, Gong Y, Zou G, Li Z, Tang B, Jiang H.
    Transl Psychiatry; 2021 Sep 17; 11(1):479. PubMed ID: 34535635
    [Abstract] [Full Text] [Related]

  • 11. Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics.
    Paulino R, Nóbrega C.
    Int J Mol Sci; 2023 Apr 17; 24(8):. PubMed ID: 37108570
    [Abstract] [Full Text] [Related]

  • 12. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11.
    Hansen SK, Borland H, Hasholt LF, Tümer Z, Nielsen JE, Rasmussen MA, Nielsen TT, Stummann TC, Fog K, Hyttel P.
    Stem Cell Res; 2016 May 17; 16(3):589-92. PubMed ID: 27346191
    [Abstract] [Full Text] [Related]

  • 13. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
    Hansen SK, Borland H, Hasholt LF, Tümer Z, Nielsen JE, Rasmussen MA, Nielsen TT, Stummann TC, Fog K, Hyttel P.
    Stem Cell Res; 2016 May 17; 16(3):553-6. PubMed ID: 27346190
    [Abstract] [Full Text] [Related]

  • 14. Machado Joseph-Disease Is Rare in the Peruvian Population.
    Cornejo-Olivas M, Solis-Ponce L, Araujo-Aliaga I, Milla-Neyra K, Ortega O, Illanes-Manrique M, Mazzetti P, Manrique-Enciso C, Cubas-Montecino D, Saraiva-Pereira ML, Jardim LB, Sarapura-Castro E.
    Cerebellum; 2023 Dec 17; 22(6):1192-1199. PubMed ID: 36323979
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induced pluripotent stem cell - derived neurons for the study of spinocerebellar ataxia type 3.
    Hansen SK, Stummann TC, Borland H, Hasholt LF, Tümer Z, Nielsen JE, Rasmussen MA, Nielsen TT, Daechsel JC, Fog K, Hyttel P.
    Stem Cell Res; 2016 Sep 17; 17(2):306-317. PubMed ID: 27596958
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Generation of induced pluripotent stem cell line (ZZUi004-A) from urine sample of a patient with spinocerebellar ataxia type 3.
    Wang Y, Shi C, Wang Z, Sun H, Yang Z, Zhang F, Liu Y, Liu H, Jiang C, Zhang S, Xu Y, Wen X.
    Stem Cell Res; 2018 Apr 17; 28():71-74. PubMed ID: 29444500
    [Abstract] [Full Text] [Related]

  • 19. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
    Ashraf NS, Sutton JR, Yang Y, Ranxhi B, Libohova K, Shaw ED, Barget AJ, Todi SV, Paulson HL, Costa MDC.
    Neurobiol Dis; 2020 Apr 17; 137():104697. PubMed ID: 31783119
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.